Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20306025 | 0.83 | ATM (0.43) | GLACACNA1BAPBA1ATMCES1 | |
| SCHEMBL16977092 | 0.81 | GLA (0.41) | GLACACNA1BAPBA1ATMCES1 | |
| SCHEMBL22134608 | 0.80 | GLA (0.41) | GLACACNA1BAPBA1ATMGAA | |
| SCHEMBL20612832 | 0.80 | GLA (0.41) | GLACACNA1BAPBA1ATMGAA | |
| SCHEMBL18868797 | 0.79 | GLA (0.35) | GLACACNA1BAPBA1ATMGAA | |
| SCHEMBL25727587 | 0.77 | KMT2A (0.39) | ATMCES1CES2MAPTPOLB | |
| SCHEMBL20821007 | 0.77 | GLA (0.39) | GLACACNA1BAPBA1ATMCES1 | |
| SCHEMBL20083134 | 0.77 | KMT2A (0.43) | GLACACNA1BAPBA1GAATDP1 | |
| SCHEMBL19789024 | 0.75 | GLA (0.31) | GLACACNA1BAPBA1 | |
| SCHEMBL19791317 | 0.75 | GLA (0.37) | GLACACNA1BAPBA1GAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021057550-A1 | ORGANIC COMPOUND AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2021-04-01 | — | — | WO | disclosed |
| US-20210036235-A1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
| EP-3706182-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Kyushu University National University Corporation (JP) | 2020-09-09 | — | — | EP | disclosed |
| US-10461258-B2 | Compound | IDEMITSU KOSAN CO., LTD. (JP) | 2019-10-29 | — | — | US | disclosed |
| US-20170186968-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10461258-B2 | Compound | CYP19A1, CYP17A1, CYP51A1 | GLA 1823/4885CACNA1B 2766/4885APBA1 623/4885 |
| US-20210036235-A1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | TRMT1, TRMT1L, DNTT | GLA 2716/4885CACNA1B 1710/4885APBA1 1886/4885 |
| US-20170186968-A1 | NOVEL COMPOUND | SREBF1, BRIX1, SREBF2 | GLA 3833/4885CACNA1B 3753/4885APBA1 653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.